UBS Oconnor LLC

SEC CIK: 0001132716
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q4 2025 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2024

Holdings of CRVS by UBS Oconnor LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−20,850−100.0%	Sold out	Holders
Q1 2025	20,850	$66.3K	<0.1%	−19,150−47.9%	Reduced	Holders
Q4 2024	40,000	$214.0K	<0.1%	+40,000	New	Holders